Therapeutic compositions comprising anti-IGE antibodies and immunosuppressive agent
AssigneeGenentech, Inc.
InventorsHenry B. Lowman, Leonard G. Presta, Paula M. Jardieu, John Lowe
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenentech, Inc.
InventorsHenry B. Lowman, Leonard G. Presta, Paula M. Jardieu, John Lowe
Estimating the term…
The present invention relates to a method for adjusting the affinity of a polypeptide to a target molecule by a combination of steps, including: (1) the identification of aspartyl residues which are prone to isomerization; (2) the substitution of alternative residues and screening the resulting mutants for affinity against the target molecule. In a preferred embodiment, the method of substituting residues is affinity maturation with phage display (AMPD). In a further preferred embodiment the polypeptide is an antibody and the target molecule is an antigen. In a further preferred embodiment, the antibody is anti-IgE and the target molecule is IgE. In another embodiment, the invention relates to an anti-IgE antibody having improved affinity to IgE.
A composition of an improved anti-IgE antibody or IgE binding fragment thereof in combination with an adjunct immunosuppressive agent, wherein the improved anti-IgE antibody or IgE binding fragment thereof comprises:
Dependencies are inferred from the claim text.